Literature DB >> 36083400

Cancer-associated vasculitides: a single-centre case series.

Hyunsue Do1, Jung Yoon Pyo1, Sung Soo Ahn1, Jason Jungsik Song1,2, Yong-Beom Park1,2, Sang-Won Lee3,4.   

Abstract

OBJECTIVES: This study investigated the frequency of cancer-associated vasculitis, the types of associated cancers and vasculitides, and the temporal relationship in Korean patients who were diagnosed with both cancers and vasculitides.
METHODS: This study performed a digital search of the clinical data repository using selected diagnostic terms of vasculitides among patients diagnosed with cancers from May 2001 to May 2021. The time gap between the time of diagnosis of 'cancers' and that of 'vasculitides' was limited to 3 years. The types of cancers and vasculitides were reviewed.
RESULTS: The mean age of 73 patients with both cancers and vasculitides with a time gap of fewer than 3 years was 53.0 years and 42.5% were men. Of the 215,897 patients with cancers, 73 patients were also diagnosed with vasculitides (0.034%). The most common type of cancer was thyroid cancer (28.8%), followed by lymphoma (13.7%), whereas the most frequent type of vasculitis associated with cancer was Behcet disease (52.1%), followed by granulomatosis with polyangiitis (12.3%). The median time gap between cancer and vasculitis was - 17.0 days. Among vasculitides, Behcet disease was closely associated with various cancers compared to other types. Twenty-one patients exhibited both cancers and vasculitides between 0 and 90 days after the diagnosis of the corresponding cancer.
CONCLUSION: The frequency of cancer-associated vasculitis was 0.034% in Korean patients. The types of cancers and vasculitides in cancer-associated vasculitis and the distributions of sex and age may be dependent on ethnic and geographic differences. Key Points • The frequency of cancer-associated vasculitis was 0.034% in Korean patients. • The most common cancer and vasculitis in cancer-associated vasculitis were thyroid cancer and Behcet disease. • The types of cancers and vasculitides in cancer-associated vasculitis seemed to be dependent on ethnic and geographic differences.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Cancers; Ethnicity; Geography; Vasculitides

Year:  2022        PMID: 36083400     DOI: 10.1007/s10067-022-06363-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  22 in total

1.  Temporal concurrence of vasculitis and cancer: a report of 12 cases.

Authors:  T E Hutson; G S Hoffman
Journal:  Arthritis Care Res       Date:  2000-12

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  Paraneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma.

Authors:  Inès Chircop; Amélie Boespflug; Antoine Cini; Jean Christophe Lega; Stéphane Dalle
Journal:  Lancet Haematol       Date:  2021-03       Impact factor: 18.959

Review 4.  Cutaneous paraneoplastic syndromes.

Authors:  Mark R Wick; James W Patterson
Journal:  Semin Diagn Pathol       Date:  2019-01-31       Impact factor: 3.464

Review 5.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

Review 6.  Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases.

Authors:  Roser Solans-Laqué; Josep Angel Bosch-Gil; Carmen Pérez-Bocanegra; Albert Selva-O'Callaghan; Carmen P Simeón-Aznar; Miquel Vilardell-Tarres
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666

7.  Vasculitides associated with malignancies: analysis of sixty patients.

Authors:  Olivier Fain; Mohamed Hamidou; Patrice Cacoub; Bertrand Godeau; Bertrand Wechsler; Jacques Pariès; Jérôme Stirnemann; Anne-Sophie Morin; Marc Gatfosse; Thomas Hanslik; Nadia Belmatoug; Olivier Blétry; Ramiro Cevallos; Isabelle Delevaux; Evelyne Fisher; Gilles Hayem; Gérard Kaplan; Claire Le Hello; Luc Mouthon; Claire Larroche; Véra Lemaire; Anne-Marie Piette; Jean-Charles Piette; Thierry Ponge; Xavier Puechal; Jérôme Rossert; Françoise Sarrot-Reynauld; Didier Sicard; Jean-Marc Ziza; Marcel-Francis Kahn; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2007-12-15

8.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

9.  Vasculitis and Breast Cancer: Mind the Hint.

Authors:  Miguel Esperança-Martins; Vasco Evangelista; Salomão Fernandes; Raquel Almeida
Journal:  Case Rep Oncol       Date:  2021-03-22

10.  Coexistence of Takayasu arteritis and chronic myeloid leukemia: Coincidental or paraneoplastic phenomenon?

Authors:  Tuba Yuce Inel; Aytac Gulcu; Ali Karakas; Elcin Erdogan Yucel; Fatos Onen
Journal:  Int J Rheum Dis       Date:  2021-07-24       Impact factor: 2.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.